Optimal conditions for olive mill wastewater treatment using ultrasound and advanced oxidation processes

© 2019 Elsevier B.V. The treatment of olive mill wastewater (OMW) in Jordan was investigated in this work using ultrasound oxidation (sonolysis) combined with other advanced oxidation processes such as ultraviolet radiation, hydrogen peroxide (H2O2) and titanium oxide (TiO2) catalyst. The efficiency of the combined oxidation process was evaluated based on the changes in the chemical oxygen demand (COD). The results showed that 59% COD removal was achieved within 90 min in the ultrasound /UV/TiO2 system. A more significant synergistic effect was observed on the COD removal efficiency when a combination of US/UV/TiO2 (sonophotocatalytic) processes was used at low ultrasound frequency. The results were then compared with the COD values obtained when each of these processes was used individually. The effects of different operating conditions such as, ultrasound power, initial COD concentration, the concentration of TiO2, frequency of ultrasound, and temperature on the OMW oxidation efficiency were studied and evaluated. The effect of adding a radical scavenger (sodium carbonate) on the OMW oxidation efficiency was investigated. The results showed that the sonophotocatalytic oxidation of OMW was affected by the initial COD, acoustic power, temperature and TiO2 concentration. The sonophotocatalytic oxidation of OMW increased with increasing the ultrasound power, temperature and H2O2 concentration. Sonolysis at frequency of 40 kHz combined with photocatalysis was not observed to have a significant effect on the OMW oxidation compared to sonication at frequency of 20 kHz. It was also found that the OMW oxidation was suppressed by the presence of the radical scavenger. The COD removal efficiency increased slightly with the increase of TiO2 concentration up to certain point due to the formation of oxidizing species. At ultrasound frequency of 20 kHz, considerable COD reduction of OMW was reported, indicating the effectiveness of the combined US/UV/TiO2 process for the OMW treatment

Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK ‘Alert Level 4’ phase of the B-MaP-C study

Abstract: Background: The B-MaP-C study aimed to determine alterations to breast cancer (BC) management during the peak transmission period of the UK COVID-19 pandemic and the potential impact of these treatment decisions. Methods: This was a national cohort study of patients with early BC undergoing multidisciplinary team (MDT)-guided treatment recommendations during the pandemic, designated ‘standard’ or ‘COVID-altered’, in the preoperative, operative and post-operative setting. Findings: Of 3776 patients (from 64 UK units) in the study, 2246 (59%) had ‘COVID-altered’ management. ‘Bridging’ endocrine therapy was used (n = 951) where theatre capacity was reduced. There was increasing access to COVID-19 low-risk theatres during the study period (59%). In line with national guidance, immediate breast reconstruction was avoided (n = 299). Where adjuvant chemotherapy was omitted (n = 81), the median benefit was only 3% (IQR 2–9%) using ‘NHS Predict’. There was the rapid adoption of new evidence-based hypofractionated radiotherapy (n = 781, from 46 units). Only 14 patients (1%) tested positive for SARS-CoV-2 during their treatment journey. Conclusions: The majority of ‘COVID-altered’ management decisions were largely in line with pre-COVID evidence-based guidelines, implying that breast cancer survival outcomes are unlikely to be negatively impacted by the pandemic. However, in this study, the potential impact of delays to BC presentation or diagnosis remains unknown